Sunitinib first-line

May 2017

Cancer

Country of origin: UK

In new guidance issued by NICE, Sunitinib is recommended as a possible first drug treatment for people with advanced and/or metastatic renal cell carcinoma if: immunotherapy (for example, interferon alfa) would be suitable for them and they are mobile and can do light housework or office work. When assessing people with disabilities, healthcare professionals should bear in mind that a person?s disability might also affect their level of physical activity. They should make adjustments for this.

Specialists should not stop prescribing sunitinib for people who were already taking it when the guidance was issued. These people should be able to carry on taking sunitinib until they and their specialist decide that it is the right time to stop treatment.

NICE has been appraising the use of bevacizumab, sorafenib, sunitinib and temsirolimus for the treatment of advanced and/or metastatic renal cell carcinoma.
Following the independent advisory Committee meeting on 14 January 2009 NICE has decided to split this appraisal in two in order to get guidance out to the NHS as quickly as possible.

NICE is also appraising the use of bevacizumab, sorafenib and temsirolimus for first-line treatment options for advanced and/or metastatic renal cell carcinoma and the two drugs also licensed for second-line treatment of advanced or metastatic renal cell carcinoma, sorafenib and sunitinib, guidance is expected to be published later this year.

The guidance is available online.

Resources

Manual for Cancer Services: Chemotherapy Measures October 2018 Following a three month consultation period the revised chemotherapy measures were published recently for inclusion in the...
QuitMedKit counseling and treatment of tobacco dependence October 2018 Tobacco use remains the number-one preventable cause of morbidity and mortality in the United States and worldwide. So it’s...
Sublux radiology app for all medical providers October 2018 What apps are available that teach the basics of plain radiography for more than just chest X-rays and ortho trauma? Are...
Study finds HPV from Oral Sex is linked to Throat Cancer September 2018 Oral sex increases the risk of transmitting the sexually transmitted human papillomavirus (HPV), suggests a new study...
Asian-language cancer information resource September 2018 About 4 million Asian Americans and Pacific Islanders have limited English proficiency, a disadvantage when it comes to...
inPractice® Oncology September 2018 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Achieving world-class cancer outcomes: a strategy for England 2015-2020 August 2018 The Independent Cancer Taskforce has published Achieving world-class cancer outcomes: a strategy for England 2015-2020....
Living with and beyond cancer - improving future survivorship services August 2018 The National Cancer Survivorship Initiative (NCSI) has published Living with and Beyond Cancer: Taking Action to Improve...
Cancer System Performance August 2018 A website allows cancer patients, their families and health care providers in Ontario, Canada, to access the province's...
Cancer statistics: availability and location July 2018 Document aims to provide an overview about cancer statistics, including information on statistics publicly available and...
Search by Keyword